Federal: HR8370

Bill Summary

HR 8370, the Dietary Supplement Listing Act of 2026, requires manufacturers of dietary supplements to register their products with the FDA and submit detailed information including ingredient lists, amounts, directions, warnings, and health claims. Each registered supplement receives a unique product listing number that must appear on labels within two years of enactment. The FDA will establish a publicly searchable database containing most submitted information, with proprietary blend amounts kept confidential. Foreign manufacturers must designate a U.S. agent to handle submissions. Non-compliance results in the supplement being deemed misbranded.

Why It Matters to MAHA

MAHA strongly supports this bill because it advances transparency and patient autonomy in the dietary supplement market without restricting access or limiting consumer choice. The requirement for detailed ingredient disclosure and a searchable FDA database empowers patients to make informed decisions about what they consume, directly aligning with MAHA's commitment to health freedom through transparency. The bill does not ban supplements, impose undue regulatory barriers, or prevent innovation in the supplement space—it simply ensures consumers have access to reliable, centralized information about product contents and safety claims. This transparency-focused approach strengthens trust in the supplement market while preserving manufacturer and consumer freedom.